Improve HPV vaccination rates at your clinic by participating in a UF and NIH study

Presented by:
Stephanie Staras, PhD

Associate Professor and Division Director,

Dept. of Health Outcomes and Biomedical Informatics,

College of Medicine,

University of Florida


Lindsay Thompson, MD

Professor and Medical Director,

Depts. Of Pediatrics and Health Outcomes and Biomedical Informatics,

College of Medicine,

University of Florida


Faculty Disclosure:

Drs. Stephanie Staras and Lindsay Thompson have disclosed they have no relevant financial relationships. No one else in a position to control content has any financial relationships to disclose.


Conflict of interest information for the CME Advisory Committee members can be found on the following website:


Release Date: April 1, 2021
Expiration Date: February 28, 2022

Target Audience:  Physicians, ARNPs, and PAs.


Learning Objectives:

Upon completion of this activity, participants should be able to:

  1. Utilize an evidence-based information for promoting the HPV vaccine.
  2. Address parents’ concerns about the HPV vaccine.
  3. Help parents make an informed decision about having their child vaccinated against HPV


Requirements for successful completion: 

Successful completion of this CME activity includes participation in the evaluation component. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:

This activity is supported by grant number R37CA234030 from the National Institutes of Health.

Resources for Further study:

  1. Fiks AG, Luan X, Mayne SL. Improving HPV Vaccination Rates Using Maintenance-of-Certification Requirements. Pediatr. 2016;137(3).e20150675. DOI: 10.1542/peds.2015-0675.
  2. Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015;33(9)(25448095).1223-1229. DOI: 10.1016/j.vaccine.2014.11.021.
  3. Kasting ML, Christy SM, Sutton SK, et al. Florida physicians’ reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med. 2018;116:143-149. DOI:10.1016/j.ypmed.2018.09.004
  4. Fairbrother G, Hanson KL, Friedman S, Butts GC. The impact of physician bonuses, enhanced fees, and feedback on childhood immunization coverage rates. American Journal of Public Health. 1999;89(2):171-175
  1. American Academy of Pediatrics, Office Strategies for Improving Immunization Rates
  2. Lollier A, Rodriguez EM, Saad-Harfouche FG, Widman CA, Mahoney MC. HPV vaccination: Pilot study assessing characteristics of high and low performing primary care offices. Prev Med Rep. 2018;10(29868360).157-161. DOI: 10.1016/j.pmedr.2018.03.002.
  3. Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang H-H, et al. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care. 2014;32(29).3656-3663.
  4. Walling EB, Dodd S, Bobenhouse N, Reis EC, Sterkel R, Garbutt J. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey. American Journal of Preventive Medicine. 2019;56(1).74-83. DOI: 10.1016/j.amepre.2018.07.038.
  5. Anna-Lisa M. Farmar, MD, MPH, a, b Kathryn Love-Osborne, MD, a, b Katherine Chichester, RN, aKristin Breslin, MPH, a Kristi Bronkan, PharmD, a Simon J. Hambidge, MD, PhD. Achieving High Adolescent HPV Vaccination Coverage. Pediatrics November 2016, 138 (5) e20152653; DOI:
  6. Rand CM, Tyrrell H, Wallace-Brodeur R, Goldstein NPN, Darden PM, Humiston SG, et al. A Learning Collaborative Model to Improve Human Papillomavirus Vaccination Rates in Primary Care. Acad Pediatr. 2018;18(2s)(29502638).S46-s52. DOI: 10.1016/j.acap.2018.01.003
  7. Perkins RB, Chigurupati NL, Apte G, et al. Why don’t adolescents finish the HPV vaccine series? A qualitative study of parents and providers. Hum Vaccin Immunother. 2016;12(6):1528-1535. DOI:10.1080/21645515.2015.1118594
  8. Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Quality & safety in health care. 2007;16(5):363-368.
  9. Jeffery A. Goad, Michael S. Taitel, Leonard E. Fensterheim and Adam E. Cannon. Vaccinations Administered During Off-Clinic Hours at a National Community Pharmacy: Implications for Increasing Patient Access and Convenience. The Annals of Family Medicine September 2013, 11 (5) 429-436; DOI:
  10. Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database of Syst Rev. 2020(1)(CD011895). DOI: 10.1002/14651858.CD011895.pub2
  11. Kempe A, O’Leary ST, Markowitz LE, Crane LA, Hurley LP, Brtnikova M, et al. HPV Vaccine Delivery Practices by Primary Care Physicians. 2019;144(4).e20191475. DOI: 10.1542/peds.2019-1475.
  12. Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial. 2017;139(1)(27940512).e20161764. DOI: 10.1542/peds.2016-1764.
  13. Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: The impact of recommendation quality. 2016;34(9)(26812078).1187-1192. DOI: 10.1016/j.vaccine.2016.01.023.
  14. Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-Parent Conversations About Human Papillomavirus Vaccination: An Analysis of Audio Recordings. J Adolesc Health. 2017;61(2)(28455129).246-251. DOI: 10.1016/j.jadohealth.2017.02.006
  15. Holloway GL. Effective HPV Vaccination Strategies: What Does the Evidence Say? An Integrated Literature Review. J Pediatr Nurs. 2019;44.31-41. DOI: 10.1016/j.pedn.2018.10.006.
  16. Eisenhauer L, Hansen BR, Pandian V. Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: A systematic review. J Clin Nurs. 2020(33270305). DOI: 10.1111/jocn.15579.
  17. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human Papillomavirus–Attributable Cancers — United States, 2012–2016. MMWR Morb Mortal Wkly Rep 2019;68:724–728. DOI 10.15585/mmwr.mm6833a3
  18. Elam-Evans LD, Yankey D, Singleton JA, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:1109–1116. DOI: 10.15585/mmwr.mm6933a1external icon

If you have any questions, please feel free to contact Shivani Desai at (352) 294-8169 or at